CancerNCT05720546
Young Adult Infusion Space Experience Satisfaction Survey
An observational study of Cancer, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.
Trial summary
The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). Read more about this study
- Who is it for?
- Ages 18 to 39 years
- Conditions the study is for
- Cancer
- What is being tested?
- Baseline Survey, Semi-structured interviews and Follow-up Survey
- Type of treatment
- Injection or infusion
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Feb 2023to 28 Jul 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 39 years
- All sexes
- Adult
Study population: A subject with a cancer diagnosis and receiving infusion in the study site
Who may be able to join
- Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- Age 18-39 years old at enrollment.
- Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
- English speaking.
Who cannot join
- Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
- Current incarceration.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27514
Hannah L Auddino, Hannah_Auddino@med.unc.edu
Jake Stein, MD MPH
About this study
Official title: Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital
The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.
- Conditions
- Cancer
- Being tested
- Baseline Survey, Semi-structured interviews, Follow-up Survey
- Keywords
- Adolescent, survey
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Baseline SurveyOther
A survey that measures participant satisfaction will be offered to participants during infusion at baseline.
Semi-structured interviewsOther
Semi-structured interviews will be conducted in the same infusion spaces.
Follow-up SurveyOther
A survey that measures participant satisfaction will be offered to participants during following infusion.
| Study group | Role | What they receive |
|---|---|---|
| Outpatient treatment center | Subjects received an infusion in an outpatient infusion center. Receives: Other: Baseline Survey; Other: Semi-structured interviews; Other: Follow-up Survey | |
| Inpatient Infusion Center | Subjects received an infusion in an inpatient infusion center. Receives: Other: Baseline Survey; Other: Semi-structured interviews; Other: Follow-up Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
General satisfaction
General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces.
Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Measured: Baseline (up to 1 month)
Secondary outcomes (3)
Satisfaction with the built environment
Subject satisfaction with the built environment will be measured with a survey item specific to the built environment administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.
Responses are rated on a Likert scale from 0 to 2. Scores will be summarized using frequency tables and percentages.
Measured: Baseline (up to 1 month)
Satisfaction with staff interaction
Subject satisfaction with staff interaction will be measured with a survey item specific to staff interactions administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.
Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Measured: Baseline (up to 1 month)
Satisfaction with mental health
Subject satisfaction with mental health will be measured with survey items regarding emotional support and comfort administered in specific infusion spaces. The result of satisfaction in different infusion sites will be compared.
Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
Measured: Baseline (up to 1 month)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2023
- Study start20 Feb 2023
- Primary completion28 Jul 2027 (estimated)
- Study completion28 Jul 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by UNC Lineberger Comprehensive Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- UNC Lineberger Comprehensive Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jacob Stein, Principal investigator, UNC Lineberger Comprehensive Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05720546
- Sponsor's protocol ID
- LCCC2228
- Status last verified
- Oct 2026
- First submitted
- 31 Jan 2023
- Last updated
- 2 Nov 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Young Adult Infusion Space Survey: Comparing Experiences of Adolescents and Young Adults in Infusion Spaces at North Carolina Basnight Cancer Hospital
- ClinicalTrials.gov ID
- NCT05720546
- Acronym / sponsor ID
- LCCC2228
- Conditions
- Cancer
- Keywords
- Adolescent, survey
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- UNC Lineberger Comprehensive Cancer CenterUniversity, hospital or other
- Study start
- 20 Feb 2023 (actual)
- Primary completion
- 28 Jul 2027 (estimated)
- Study completion
- 28 Jul 2027 (estimated)
- First posted
- 9 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to compare the satisfaction of Adolescent and Young Adults (AYA) receiving treatment in two different infusion spaces at the North Carolina Basnight Cancer Hospital (NCBCH). A survey and semi-structured interviews will be administered to participants to compare the experience with the built environment, with mental health staff, and between outpatient infusion spaces at NCBCH.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Outpatient treatment center | – | Other: Baseline Survey, Other: Semi-structured interviews, Other: Follow-up SurveySubjects received an infusion in an outpatient infusion center. |
| Inpatient Infusion Center | – | Other: Baseline Survey, Other: Semi-structured interviews, Other: Follow-up SurveySubjects received an infusion in an inpatient infusion center. |
Who may qualify
- Ages
- 18 to 39 years
- Sex
- All
- Age groups
- Adult
- Study population
- A subject with a cancer diagnosis and receiving infusion in the study site
Key inclusion criteria (5 listed)
- Written informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- Age 18-39 years old at enrollment.
- Receiving treatment for a cancer diagnosis in Adult Infusion Center or the Adolescent and Young Adult Infusion Center
- English speaking.
Key exclusion criteria (2 listed)
- Dementia, altered mental status, or any psychiatric condition as determined by the clinical or study team that would prohibit the understanding or rendering of informed consent.
- Current incarceration.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Baseline SurveyA survey that measures participant satisfaction will be offered to participants during infusion at baseline. | Other | Inpatient Infusion Center, Outpatient treatment center |
| Semi-structured interviewsSemi-structured interviews will be conducted in the same infusion spaces. | Other | Inpatient Infusion Center, Outpatient treatment center |
| Follow-up SurveyA survey that measures participant satisfaction will be offered to participants during following infusion. | Other | Inpatient Infusion Center, Outpatient treatment center |
Primary outcome
General satisfaction
Time frame: Baseline (up to 1 month)
General satisfaction will be measured with participants' responses to satisfaction surveys that will be administered in specific infusion spaces. Responses are rated on a Likert scale from 0 to 4. Scores will be summarized using frequency tables and percentages.
3 secondary outcomes
Satisfaction with the built environment
Time frame: Baseline (up to 1 month)
Satisfaction with staff interaction
Time frame: Baseline (up to 1 month)
Satisfaction with mental health
Time frame: Baseline (up to 1 month)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Nov 2026.
- University of North Carolina Lineberger Comprehensive Cancer Center Clinical TrialsLink provided by the sponsor.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Jacob Stein principal investigator
UNC Lineberger Comprehensive Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Hannah Auddino (919-928-6231, Hannah_Auddino@med.unc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
General satisfaction (time frame: Baseline (up to 1 month)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.